Now showing items 1-8
Docetaxel (1) |
Lutetium-177 (177Lu) (1) |
Metastatic castrate-resistant prostate cancer (mCRPC) (1) |
Prostate cancer (1) |
Prostate-specific membrane antigen (PSMA) (1) |
Radioligand therapy (RLT) (1) |
Radiosensitizer (1) |
Re-challenge (1) |
Now showing items 1-8